Reference Materials for the Standardization of the Apolipoproteins A-I and B, and Lipoprotein(a)
- PMID: 30416418
- PMCID: PMC6222398
Reference Materials for the Standardization of the Apolipoproteins A-I and B, and Lipoprotein(a)
Abstract
Measurement of the apolipoproteins A-I and B, and lipoprotein(a) enable identification of individuals at increased risk of cardiovascular disease. However, the lack of standardized methods to measure these risk markers has resulted for many years in the non-comparability of values and often a conflicting interpretation of clinical studies. Due to the collaborative efforts of the International Federation of Clinical Chemistry and Laboratory Medicine, research organizations, clinical chemistry laboratories and diagnostic companies, secondary reference materials for the apolipoproteins A-I and B, and lipoprotein(a) have been prepared and tested for their ability to harmonize test values. SP1-01 and SP3-07 WHO-IFCC reagents are now available to manufacturers for use in the value transfer of apolipoprotein A-I and B values to master calibrators, and PRM is proposed to be the secondary reference material for Lp(a). By the worldwide use of such reference materials a better traceability and standardization of measurement is being achieved in the clinical laboratories.
Figures
Similar articles
-
First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B.Clin Chem Lab Med. 2004;42(6):670-6. doi: 10.1515/CCLM.2004.114. Clin Chem Lab Med. 2004. PMID: 15259385
-
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material.Clin Chem. 1993 May;39(5):773-81. Clin Chem. 1993. PMID: 8485867
-
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a).Clin Chem. 2000 Dec;46(12):1956-67. Clin Chem. 2000. PMID: 11106328
-
The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.Clin Lab Med. 1989 Mar;9(1):105-35. Clin Lab Med. 1989. PMID: 2538292 Review.
-
Standardization of apolipoprotein B and A-I measurements.Clin Chem. 1989 Jul;35(7):1357-61. Clin Chem. 1989. PMID: 2503261 Review.
Cited by
-
Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer.Pract Lab Med. 2021 Mar 24;25:e00218. doi: 10.1016/j.plabm.2021.e00218. eCollection 2021 May. Pract Lab Med. 2021. PMID: 33898688 Free PMC article.
-
The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs.J Am Soc Mass Spectrom. 2021 Mar 3;32(3):636-647. doi: 10.1021/jasms.0c00379. Epub 2021 Feb 1. J Am Soc Mass Spectrom. 2021. PMID: 33522792 Free PMC article.
References
-
- Rifai N, Warnick GR, Dominiczak MH. Handbook of lipoprotein testing. Washington, DC: AACC Press, 2000.
-
- Rifai N, Chapman JF, Siverman LM, Gwynnes JT. Review of serum lipids and apolipoproteins in risk assessment of coronary hearT disease. Ann Clin Lab Sci 1988:18:429-439. - PubMed
-
- Rossenau M, Widhalm K, Jarausch J. Apolipoproteins in lipid disorders. Vienna, New York: Springer-Verlag; 1991.
-
- Brewer HB, Gregg RE, Hoeg JM, Fojo SS. Apolipoproteins and lipoproteins in human plasma: an overview. Clin Chem 1988:34:B4-B8. - PubMed
-
- Marcovina SM, Koschinsky ML. Lipoprotein(a): structure, measurement, and clinical significance. Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of lipoprotein testing. Washington, DC: AACC Press, 2000: 345-385.
LinkOut - more resources
Full Text Sources
Miscellaneous